IN2014DN07831A - - Google Patents

Info

Publication number
IN2014DN07831A
IN2014DN07831A IN7831DEN2014A IN2014DN07831A IN 2014DN07831 A IN2014DN07831 A IN 2014DN07831A IN 7831DEN2014 A IN7831DEN2014 A IN 7831DEN2014A IN 2014DN07831 A IN2014DN07831 A IN 2014DN07831A
Authority
IN
India
Prior art keywords
modafinil
less
pharmaceutical composition
hours
cocaine
Prior art date
Application number
Other languages
English (en)
Inventor
Pascal Suplie
Philippe Vivet
Original Assignee
Debregeas Et Associes Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debregeas Et Associes Pharma filed Critical Debregeas Et Associes Pharma
Publication of IN2014DN07831A publication Critical patent/IN2014DN07831A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
IN7831DEN2014 2012-02-28 2013-02-25 IN2014DN07831A (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1200581A FR2987267B1 (fr) 2012-02-28 2012-02-28 Application du modafinil dans le traitement de substitution des cacainomanes
PCT/FR2013/000052 WO2013128088A1 (fr) 2012-02-28 2013-02-25 Application du modafinil dans le traitement des cocaïnomanes

Publications (1)

Publication Number Publication Date
IN2014DN07831A true IN2014DN07831A (it) 2015-04-24

Family

ID=48083447

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7831DEN2014 IN2014DN07831A (it) 2012-02-28 2013-02-25

Country Status (33)

Country Link
US (1) US20150073055A1 (it)
EP (1) EP2819655B1 (it)
JP (1) JP6163169B2 (it)
KR (1) KR101897855B1 (it)
CN (1) CN104159575B (it)
AR (1) AR090169A1 (it)
AU (1) AU2013224831B2 (it)
BR (1) BR112014020626A2 (it)
CA (1) CA2863159C (it)
CL (1) CL2014002203A1 (it)
CY (1) CY1118166T1 (it)
DK (1) DK2819655T3 (it)
EA (1) EA025692B1 (it)
ES (1) ES2593276T3 (it)
FR (1) FR2987267B1 (it)
HR (1) HRP20161165T1 (it)
HU (1) HUE030737T2 (it)
IL (1) IL234009B (it)
IN (1) IN2014DN07831A (it)
LT (1) LT2819655T (it)
MX (1) MX348222B (it)
NZ (1) NZ628009A (it)
PH (1) PH12014501837A1 (it)
PL (1) PL2819655T3 (it)
PT (1) PT2819655T (it)
RS (1) RS55238B1 (it)
SG (1) SG11201405316WA (it)
SI (1) SI2819655T1 (it)
SM (1) SMT201600363B (it)
TW (1) TWI626042B (it)
UA (1) UA113301C2 (it)
WO (1) WO2013128088A1 (it)
ZA (1) ZA201405910B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105055404B (zh) * 2015-08-19 2017-07-18 四川大学 Hmgcs2抑制剂在制备治疗可卡因成瘾的药物中的用途
CN105055412B (zh) * 2015-08-20 2018-06-19 四川大学 Nampt抑制剂在制备治疗可卡因成瘾的药物中的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
FR2771004B1 (fr) 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
US20010034373A1 (en) 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
BR0114814A (pt) * 2000-10-11 2005-01-25 Cephalon Inc Composições compreendendo composto de modafinila e seu uso
US20040006532A1 (en) 2001-03-20 2004-01-08 David Lawrence Network access risk management
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
US7093476B2 (en) 2004-09-15 2006-08-22 Ut-Battelle, Llc Method for fabricating thin californium-containing radioactive source wires
WO2007013962A2 (en) * 2005-07-21 2007-02-01 Neurohealing Pharmaceuticals, Inc. Rapid onset and short term modafinil compositions and methods of use thereof
BRPI0714173A2 (pt) * 2006-07-12 2012-12-25 Elan Pharma Int Ltd composiÇço nanoparticulada estÁvel,mÉtodos para preparar a composiÇço, para prevenir e/ou tratar estados de doenÇas, sintomas, sÍndromes e condiÇÕes do sistema nervoso central, para melhorar ou manter a biodisponibilidade de modafinil, e para tratar distérbio com base neurolàgica, composiÇço farmacÊutica, e forma de dosagem
EP1980240A1 (en) * 2007-04-11 2008-10-15 Cephalon France Lyophilized pharmaceutical compositions and methods of making and using same
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil

Also Published As

Publication number Publication date
RS55238B1 (sr) 2017-02-28
MX348222B (es) 2017-06-05
WO2013128088A8 (fr) 2014-09-12
LT2819655T (lt) 2016-10-25
TWI626042B (zh) 2018-06-11
CY1118166T1 (el) 2017-06-28
EP2819655A1 (fr) 2015-01-07
HRP20161165T1 (hr) 2016-11-04
EA025692B1 (ru) 2017-01-30
HUE030737T2 (en) 2017-05-29
ES2593276T3 (es) 2016-12-07
EP2819655B1 (fr) 2016-07-27
DK2819655T3 (en) 2016-11-28
UA113301C2 (xx) 2017-01-10
SMT201600363B (it) 2016-11-10
NZ628009A (en) 2015-07-31
JP2015508805A (ja) 2015-03-23
PT2819655T (pt) 2016-10-14
CA2863159C (fr) 2018-06-12
BR112014020626A2 (pt) 2017-06-27
TW201340964A (zh) 2013-10-16
PL2819655T3 (pl) 2017-01-31
AU2013224831B2 (en) 2017-05-11
FR2987267B1 (fr) 2015-01-16
ZA201405910B (en) 2017-04-26
AR090169A1 (es) 2014-10-22
SG11201405316WA (en) 2014-11-27
CL2014002203A1 (es) 2015-04-10
SI2819655T1 (sl) 2016-11-30
WO2013128088A1 (fr) 2013-09-06
CN104159575B (zh) 2018-09-04
CN104159575A (zh) 2014-11-19
CA2863159A1 (fr) 2013-09-06
AU2013224831A1 (en) 2014-08-21
FR2987267A1 (fr) 2013-08-30
IL234009A0 (en) 2014-09-30
EA201400960A1 (ru) 2014-12-30
IL234009B (en) 2018-01-31
US20150073055A1 (en) 2015-03-12
KR101897855B1 (ko) 2018-09-12
KR20140135162A (ko) 2014-11-25
PH12014501837A1 (en) 2014-11-10
MX2014010237A (es) 2015-07-17
JP6163169B2 (ja) 2017-07-12

Similar Documents

Publication Publication Date Title
PH12016500040A1 (en) Pcsk9 vaccine
NZ734152A (en) Compounds, compositions and methods useful for cholesterol mobilisation
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
IN2014MN01755A (it)
EA201690107A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
MY179703A (en) Dry powder formulation comprising a phosphodiesterase inhibitor
MY173215A (en) Acetylcysteine compositions and methods of use thereof
PH12016500746B1 (en) A novel formulation of meloxicam
MY156302A (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ß-AMYLOID DISEASES AND SYNUCLEINOPATHIES
IN2015DN03854A (it)
TN2011000536A1 (en) A novel formulation of naproxen
EA033054B1 (ru) Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
NZ719087A (en) Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
PH12014501837A1 (en) Use of modafinil in the treatment of cocaine addicts
ZA201207173B (en) Substitution derivatives of n6-benzyladenosine-5'-monophosphate,methods of preparation thereof,use thereof as medicaments,and therapeutic preparation containing these compounds
IN2013MU01239A (it)
IN2013MU01243A (it)
IN2013MU01241A (it)
IN2013MU01240A (it)
IN2013MU01245A (it)
IN2013MU01246A (it)
IN2013MU01247A (it)
IN2013MU01244A (it)
IN2013MU01248A (it)